Mechanisms of CLC Transporters and Channels

CLC转运蛋白和通道的机制

• 批准号: 9174309
• 负责人: Merritt C Maduke
• 金额: $ 46.21万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-01 至 2020-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9174309
• 关键词: Active Biological Transport; Affect; Binding; Biochemical; Carrier Proteins; Chloride Channels; Chloride Ion; Chlorides; Chronic; Computer Analysis; Computer Simulation; Constipation; Coupled; Coupling; Crystallization; Crystallography; Development; Disease; Electron Spin Resonance Spectroscopy; Electrons; Electrophysiology (science); Elements; Event; Failure; Family; Gene Family; Goals; Homologous Gene; Human; Hypertension; Hyponatremia; Ion Channel; Ion Transport; Ions; Kidney Diseases; Kinetics; Measurement; Measures; Medical; Membrane; Membrane Proteins; Membrane Transport Proteins; Methodology; Methods; Modeling; Molecular; Molecular Conformation; Movement; Muscle; Organism; Osteoporosis; Pathway interactions; Process; Proteins; Proton Pump; Protons; Resolution; Side; Site; Spin Labels; Structural Models; Structure; Techniques; Testing; Therapeutic; Tissues; Validation; Variant; Water; Work; antiporter; biophysical techniques; bone; inhibitor/antagonist; innovation; insight; leukodystrophy; molecular dynamics; mutant; nervous system disorder; public health relevance; reconstitution; simulation; stoichiometry; tool

The long-term goal of this project is to develop a detailed molecular understanding of the CLC ("Chloride Channel") family of membrane proteins. The CLCs comprise two major classes of ion-transport mechanisms: half of CLC homologs are electrodiffusive ion channels (catalyzing downhill movement of chloride), while the other half are secondary active transporters that stoichiometrically exchange chloride for protons (harnessing the energy from movement of chloride to pump protons or vice versa). That both types of ion-transport are within one gene family suggests their mechanisms may be subtle variations on a single central theme. Indeed, CLC channels appear to act by a "broken transporter" mechanism. Here we propose a highly concerted approach composed of complementary computational and experimental biophysical and biochemical techniques to study the molecular details underpinning the mechanism of CLC-ec1 and CLC-0, model homologs for antiporters and channels, respectively. Our main goal is to elucidate the antiporter ("unbroken") mechanism, taking advantage of high-resolution CLC-ec1 structures and the molecular dynamics simulations they allow, and of antiporter amenability to spectroscopic analysis. We will apply insights from studies of the "unbroken" transporter CLC-ec1 to electrophysiological analysis of the CLC-0 channel's "broken" mechanism to study conservation between channel and transporter mechanisms. AIM 1 will determine global structural changes associated with the CLC transport cycle. Here we will use EPR to measure distance changes between pairs of site-directed spin labels on CLC-ec1, evaluate changes in accessibility of spin labels, and use computational modeling to develop structural models for the inward- and outward-facing states. AIM 2 will determine how CLC conformational change affects water dynamics and water-wire formation involved in proton transport. These studies will help reveal how proton transport fits into the overall CLC transport mechanism. AIM 3 will characterize the chloride/proton coupling mechanism – evaluating detailed models of how transport occurs, using a combination of kinetic and spectroscopic measurements on WT and uncoupled mutants, together with computational analysis to investigate in detail how binding and translocation of ions are coupled to protein conformational changes. Overall Impact: Revealing molecular details of CLC ion channel "broken" and antiporter "unbroken" mechanisms, and how they are alike and different, will help reveal how CLC function can go wrong, with implications for neurological diseases, hypertension, and diseases of kidney, muscle, and bone. Our methodology will be applicable to other large membrane proteins of medical importance where unraveling molecular mechanisms has similarly been stymied by limitations of crystallography.

这个项目的长期目标是发展对CLC(氯化物)的详细的分子理解 “通道”)膜蛋白家族。CLCs包括两类主要的离子传输机制： 一半的CLC同系物是电扩散离子通道(催化氯的下坡移动)，而 另一半是二级活性转运体，按化学计量交换氯化物为质子(利用 从氯化物运动到泵浦质子或反之亦然的能量)。两种类型的离子传输都是 在一个基因家族中，他们的机制可能是单一中心主题上的微妙变化。 事实上，《中图法》频道似乎是通过一种“坏掉的传输器”机制起作用的。在这里，我们提出一个高度的 由互补的计算和实验生物物理和 用生物化学技术研究支持ClC-EC1和ClC-0机制的分子细节， 分别为反向转运蛋白和通道的模型同系物。我们的主要目标是阐明逆向转运蛋白 (“完整”)机制，利用高分辨率的ClC-EC1结构和分子 它们允许的动力学模拟，以及反向转运体对光谱分析的适应性。我们会申请 连续转运体ClC-EC1的研究对CLC-0电生理分析的启示 研究通道和转运体之间的守恒机制的“断裂”机制。目标1 将决定与《中图法》运输周期相关的全球结构变化。在这里，我们将使用EPR 测量CLC-EC1上定点定向自旋标记对之间的距离变化，评估 自旋标签的可及性，并使用计算建模来开发向内和向内的结构模型 外向型国家。目标2将确定CLC构象变化如何影响水动力学和 参与质子运输的水线形成。这些研究将有助于揭示质子传输如何适用于 整体的CLC传输机制。目标3将描述氯/质子耦合机制- 使用动力学和光谱相结合的方法，评估运输如何发生的详细模型 WT和非偶联突变体的测量，以及详细研究的计算分析 离子的结合和移位如何与蛋白质构象变化相偶联。 整体影响：揭示CLC离子通道“断裂”和逆向转运体“未断裂”的分子细节 机制，以及它们的相似和不同之处，将有助于揭示CLC功能如何出错， 对神经系统疾病、高血压以及肾脏、肌肉和骨骼疾病的影响。我们的 方法学将适用于其他具有医学意义的大型膜蛋白 分子机制同样也受到结晶学限制的阻碍。